热门出版物 - 学术资源搜索

h5 指数:56
h5 中位数:78

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#11 Vascular Medicine

标题/作者	引用次数	年份
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension B Williams, G Mancia, W Spiering, EA Rosei, M Azizi, M Burnier, ... Journal of Hypertension 36 (10), 1953-2041	7759	2018
2020 International Society of Hypertension global hypertension practice guidelines T Unger, C Borghi, F Charchar, NA Khan, NR Poulter, D Prabhakaran, ... Journal of Hypertension 38 (6), 982-1004	1366	2020
2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: ESC/ESH Task Force for the Management of Arterial Hypertension B Williams, G Mancia, W Spiering, EA Rosei, M Azizi, M Burnier, ... Journal of Hypertension 36 (12), 2284-2309	363	2018
A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement GS Stergiou, B Alpert, S Mieke, R Asmar, N Atkins, S Eckert, G Frick, ... Journal of Hypertension 36 (3), 472-478	297	2018
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? M Esler, D Esler Journal of Hypertension 38 (5), 781-782	288	2020
First international consensus on the diagnosis and management of fibromuscular dysplasia HL Gornik, A Persu, D Adlam, LS Aparicio, M Azizi, M Boulanger, ... Journal of Hypertension 37 (2), 229-252	223	2019
Sources of inaccuracy in the measurement of adult patients’ resting blood pressure in clinical settings: a systematic review N Kallioinen, A Hill, MS Horswill, HE Ward, MO Watson Journal of Hypertension 35 (3), 421-441	219	2017
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10–Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials C Thomopoulos, G Parati, A Zanchetti Journal of Hypertension 35 (5), 922-944	213	2017
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH) PA Sarafidis, A Persu, R Agarwal, M Burnier, P de Leeuw, C Ferro, ... Journal of Hypertension 35 (4), 657-676	192	2017
White-coat hypertension is a risk factor for cardiovascular diseases and total mortality Y Huang, W Huang, W Mai, X Cai, D An, Z Liu, H Huang, J Zeng, Y Hu, ... Journal of Hypertension 35 (4), 677-688	164	2017
Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2 VB Matthews, RH Elliot, C Rudnicka, J Hricova, L Herat, MP Schlaich Journal of Hypertension 35 (10), 2059-2068	131	2017
Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis J Wang, X Shi, C Ma, H Zheng, J Xiao, H Bian, Z Ma, L Gong Journal of Hypertension 35 (1), 10-17	124	2017
Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials C Thomopoulos, G Parati, A Zanchetti Journal of Hypertension 35 (11), 2150-2160	119	2017
Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis H Durand, P Hayes, EC Morrissey, J Newell, M Casey, AW Murphy, ... Journal of Hypertension 35 (12), 2346-2357	116	2017
CELLULAR AND GENETIC CAUSES OF IDIOPATHIC HYPERALDOSTERONISM K Omata, R Morimoto, S Ito, Y Yamazaki, Y Nakamura, S Anand, Z Guo, ... JOURNAL OF HYPERTENSION 36, E74-E74	116	2018
The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? BM Egan, SE Kjeldsen, G Grassi, M Esler, G Mancia Journal of Hypertension 37 (6), 1148-1153	115	2019
Sodium butyrate suppresses angiotensin II-induced hypertension by inhibition of renal (pro) renin receptor and intrarenal renin–angiotensin system L Wang, Q Zhu, A Lu, X Liu, L Zhang, C Xu, X Liu, H Li, T Yang Journal of Hypertension 35 (9), 1899-1908	109	2017
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions V Kotsis, K Tsioufis, C Antza, G Seravalle, A Coca, C Sierra, E Lurbe, ... Journal of Hypertension 36 (7), 1441-1455	104	2018
Arterial stiffness index beta and cardio-ankle vascular index inherently depend on blood pressure but can be readily corrected B Spronck, AP Avolio, I Tan, M Butlin, KD Reesink, T Delhaas Journal of Hypertension 35 (1), 98-104	100	2017
The effect of vitamin D on renin–angiotensin system activation and blood pressure: a randomized control trial CJ McMullan, L Borgi, GC Curhan, N Fisher, JP Forman Journal of Hypertension 35 (4), 822-829	95	2017

1 - 20

计算机程序会自动估算并确定日期和引用次数。